BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35916535)

  • 1. Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).
    Vats A; Trejo-Cerro O; Massimi P; Banks L
    J Virol; 2022 Aug; 96(16):e0066322. PubMed ID: 35916535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of E6AP-independent degradation targets of HPV E6.
    Vats A; Thatte J; Banks L
    J Gen Virol; 2019 Dec; 100(12):1674-1679. PubMed ID: 31609195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1.
    Drews CM; Case S; Vande Pol SB
    PLoS Pathog; 2019 Apr; 15(4):e1007575. PubMed ID: 31002735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.
    Tomaić V; Pim D; Banks L
    Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.
    Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM
    J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
    Drews CM; Brimer N; Vande Pol SB
    PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
    Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
    J Virol; 2024 Feb; 98(2):e0172623. PubMed ID: 38226814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.
    Zanier K; Charbonnier S; Baltzinger M; Nominé Y; Altschuh D; Travé G
    J Mol Biol; 2005 Jun; 349(2):401-12. PubMed ID: 15890204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells.
    Talis AL; Huibregtse JM; Howley PM
    J Biol Chem; 1998 Mar; 273(11):6439-45. PubMed ID: 9497376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of HPV E6 oncoproteins with specific proteasomal subunits.
    Tomaić V; Ganti K; Pim D; Bauer C; Blattner C; Banks L
    Virology; 2013 Nov; 446(1-2):389-96. PubMed ID: 24074603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6.
    Ebner FA; Sailer C; Eichbichler D; Jansen J; Sladewska-Marquardt A; Stengel F; Scheffner M
    J Biol Chem; 2020 Oct; 295(44):15070-15082. PubMed ID: 32855237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warts, cancer and ubiquitylation: lessons from the papillomaviruses.
    Howley PM
    Trans Am Clin Climatol Assoc; 2006; 117():113-26; discussion 126-7. PubMed ID: 18528468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Felis catus papillomavirus type-2 E6 binds to E6AP, promotes E6AP/p53 binding and enhances p53 proteasomal degradation.
    Altamura G; Power K; Martano M; Degli Uberti B; Galiero G; De Luca G; Maiolino P; Borzacchiello G
    Sci Rep; 2018 Dec; 8(1):17529. PubMed ID: 30510267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
    Wang J; Sampath A; Raychaudhuri P; Bagchi S
    Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the human papillomavirus type 18 E6/E6AP ubiquitin ligase complex by the HECT domain-containing protein EDD.
    Tomaic V; Pim D; Thomas M; Massimi P; Myers MP; Banks L
    J Virol; 2011 Apr; 85(7):3120-7. PubMed ID: 21228227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
    Gao Q; Kumar A; Singh L; Huibregtse JM; Beaudenon S; Srinivasan S; Wazer DE; Band H; Band V
    Cancer Res; 2002 Jun; 62(11):3315-21. PubMed ID: 12036950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.
    Huh K; Zhou X; Hayakawa H; Cho JY; Libermann TA; Jin J; Harper JW; Munger K
    J Virol; 2007 Sep; 81(18):9737-47. PubMed ID: 17609271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitination of the HPV Oncoprotein E6 Is Critical for E6/E6AP-Mediated p53 Degradation.
    Li S; Hong X; Wei Z; Xie M; Li W; Liu G; Guo H; Yang J; Wei W; Zhang S
    Front Microbiol; 2019; 10():2483. PubMed ID: 31749782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.